Mara M. Epstein

1.3k total citations
61 papers, 822 citations indexed

About

Mara M. Epstein is a scholar working on Oncology, Pathology and Forensic Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Mara M. Epstein has authored 61 papers receiving a total of 822 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 14 papers in Pathology and Forensic Medicine and 14 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Mara M. Epstein's work include Global Cancer Incidence and Screening (12 papers), Multiple Myeloma Research and Treatments (9 papers) and Colorectal Cancer Screening and Detection (9 papers). Mara M. Epstein is often cited by papers focused on Global Cancer Incidence and Screening (12 papers), Multiple Myeloma Research and Treatments (9 papers) and Colorectal Cancer Screening and Detection (9 papers). Mara M. Epstein collaborates with scholars based in United States, Sweden and Puerto Rico. Mara M. Epstein's co-authors include Lorelei A. Mucci, Jennifer R. Rider, Hans‐Olov Adami, Gustaf Edgren, Edward L. Giovannucci, Katja Fall, Alicja Wolk, Brenda M. Birmann, Ove Andrén and Niclas Håkansson and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Mara M. Epstein

59 papers receiving 807 citations

Peers

Countries citing papers authored by Mara M. Epstein

Since Specialization

Citations

This map shows the geographic impact of Mara M. Epstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mara M. Epstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mara M. Epstein more than expected).

Fields of papers citing papers by Mara M. Epstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mara M. Epstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mara M. Epstein. The network helps show where Mara M. Epstein may publish in the future.

Co-authorship network of co-authors of Mara M. Epstein

This figure shows the co-authorship network connecting the top 25 collaborators of Mara M. Epstein. A scholar is included among the top collaborators of Mara M. Epstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mara M. Epstein. Mara M. Epstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Long COVID awareness and receipt of medical care: a survey among populations at risk for disparities 2024 ·Frontiers in Public Health ·Kimberly A. Fisher, Kathleen M. Mazor, Mara M. Epstein, (unknown), (unknown), Yanhua Zhou, Sybil L. Crawford, Jai Marathe, Benjamin P. Linas	3
2	Time to treatment initiation for breast, prostate, non-small cell lung, and colon cancers from 2018 to 2022. 2024 ·Journal of Clinical Oncology ·(unknown), (unknown), Allison Crawford, (unknown), Mara M. Epstein, Catherine Gray, Feiran Lou, Mark W. Maxfield, Karl Uy, Isabel Cristina Martins Emmerick	2
3	“Go ahead and screen” - advice to healthcare systems for routine lynch syndrome screening from interviews with newly diagnosed colorectal cancer patients 2023 ·Hereditary Cancer in Clinical Practice ·Jennifer L. Schneider, Alison Firemark, (unknown), James V. Davis, Pamala A. Pawloski, Su‐Ying Liang, Mara M. Epstein, Jan T. Lowery, Christine Y. Lu, Ravi Sharaf, Andrea N. Burnett‐Hartman, (unknown), Zachary Salvati, Deborah Cragun, Alanna Kulchak Rahm, Jessica Ezzell Hunter	0
4	Multimorbidity in patients with monoclonal gammopathy of undetermined significance 2023 ·International Journal of Cancer ·Mara M. Epstein, Yanhua Zhou, (unknown), Harvey Jay Cohen	1
5	Trends and Factors Associated with Fecal Occult Blood Test Utilization among Hispanic Adults in Puerto Rico and the United States: BRFSS 2012–2020 2023 ·Cancer Prevention Research ·(unknown), (unknown), Mara M. Epstein, Karen J. Ortiz‐Ortiz, Guillermo Tortolero‐Luna, Kate L. Lapane	1
6	Uptake of HPV Vaccine among young adults with disabilities, 2011 to 2018 2022 ·Disability and health journal ·Carly Herbert, Carol Curtin, Mara M. Epstein, Bo Wang, Kate L. Lapane	4
7	Association Between Body Mass Index and Cancer Screening Adherence Among Latinas in the United States and Puerto Rico 2022 ·Women s Health Reports ·(unknown), Jonggyu Baek, Mara M. Epstein, Sarah Forrester, Ana P. Ortíz, Kate L. Lapane	2
8	Defining Multimorbidity and Its Impact in Older United States Veterans Newly Treated for Multiple Myeloma 2021 ·JNCI Journal of the National Cancer Institute ·Nathanael R. Fillmore, Clark DuMontier, (unknown), Jennifer La, Mara M. Epstein, David Cheng, Diana Cirstea, Sarvari V. Yellapragada, Gregory A. Abel, J. Michael Gaziano, Nhan Do, Mary T. Brophy, Dae Hyun Kim, Nikhil C. Munshi, Jane A. Driver	11
9	Impact of COVID-19 on breast andprostate cancer screening and early detection in a largehealth care provider group 2020 ·Clinical Cancer Research ·Mara M. Epstein, Devi Sundaresan, (unknown), Lawrence Garber, (unknown), Jerry H. Gurwitz, Terry S. Field	0
10	Prostate-specific antigen testing after the US Preventive Services Task Force recommendation: a population-based analysis of electronic health data 2020 ·Cancer Causes & Control ·Daniel M. Frendl, Mara M. Epstein, Hassan Fouayzi, Richard Krajenta, Benjamin A. Rybicki, Mitchell H. Sokoloff	4
11	Screening mammography among nursing home residents in the United States: Current guidelines and practice 2018 ·Journal of Geriatric Oncology ·Deborah S. Mack, Mara M. Epstein, Catherine Dubé, Robin E. Clark, Kate L. Lapane	2
12	Implementing universal Lynch syndrome screening (IMPULSS): protocol for a multi-site study to identify strategies to implement, adapt, and sustain genomic medicine programs in different organizational contexts 2018 ·BMC Health Services Research ·Alanna Kulchak Rahm, Deborah Cragun, Jessica Ezzell Hunter, Mara M. Epstein, Jan T. Lowery, Christine Y. Lu, Pamala A. Pawloski, Ravi Sharaf, Su‐Ying Liang, Andrea N. Burnett‐Hartman, (unknown), Jing Hao, Susan Snyder, Radhika Gogoi, Ilene Ladd, Marc S. Williams	29
13	Pre-diagnosis plasma immune markers and risk of non-Hodgkin lymphoma in two prospective cohort studies 2018 ·Haematologica ·Mara M. Epstein, Bernard Rosner, Elizabeth C. Breen, Julie L. Batista, Edward L. Giovannucci, Larry Magpantay, Jon C. Aster, Scott J. Rodig, Kimberly A. Bertrand, Francine Laden, Otoniel Martı́nez-Maza, Brenda M. Birmann	7
14	Detecting Cases of Monoclonal Gammopathy of Undetermined Significance in Electronic Health Data 2017 ·Blood ·Mara M. Epstein, (unknown), Yanhua Zhou, Brenda M. Birmann, (unknown), Alan G. Rosmarin, Jerry H. Gurwitz	1
15	Influence of Dietary Patterns on Plasma Soluble CD14, a Surrogate Marker of Gut Barrier Dysfunction 2017 ·Current Developments in Nutrition ·Fred K. Tabung, Brenda M. Birmann, Mara M. Epstein, Otoniel Martı́nez-Maza, Elizabeth C. Breen, Kana Wu, Edward L. Giovannucci	29
16	Training in the Conduct of Population-Based Multi-Site and Multi-Disciplinary Studies: the Cancer Research Network’s Scholars Program 2015 ·Journal of Cancer Education ·Diana S.M. Buist, Terry S. Field, Matthew P. Banegas, Heather Clancy, V. Paul Doria‐Rose, Mara M. Epstein, Robert T. Greenlee, Sarah D. McDonald, Hazel B. Nichols, Pamala A. Pawloski, Lawrence H. Kushi	7
17	A Single Nucleotide Polymorphism in Inflammatory Gene RNASEL Predicts Outcome after Radiation Therapy for Localized Prostate Cancer 2013 ·Clinical Cancer Research ·Jonathan D. Schoenfeld, Danielle N. Margalit, Julie L. Kasperzyk, Irene M. Shui, Jennifer R. Rider, Mara M. Epstein, Allison Meisner, Stacey A. Kenfield, Neil E. Martin, Paul L. Nguyen, Philip W. Kantoff, Edward L. Giovannucci, Meir J. Stampfer, Lorelei A. Mucci	14
18	Seasonal variation in expression of markers in the vitamin D pathway in prostate tissue 2012 ·Cancer Causes & Control ·Mara M. Epstein, Ove Andrén, Julie L. Kasperzyk, Irene M. Shui, Kathryn L. Penney, Katja Fall, Jennifer R. Rider, Meir J. Stampfer, Swen‐Olof Andersson, Edward L. Giovannucci, Lorelei A. Mucci	5
19	Genetic variation in the toll‐like receptor 4 and prostate cancer incidence and mortality 2011 ·The Prostate ·Irene M. Shui, Jennifer R. Rider, Kathryn L. Penney, Fredrick R. Schumacher, Mara M. Epstein, Michael J. Pitt, Meir J. Stampfer, Rulla M. Tamimi, Sara Lindström, Howard D. Sesso, Katja Fall, Jing Ma, Peter Kraft, Edward L. Giovannucci, Lorelei A. Mucci	19
20	Dietary zinc and prostate cancer survival in a Swedish cohort 2011 ·American Journal of Clinical Nutrition ·Mara M. Epstein, Julie L. Kasperzyk, Ove Andrén, Edward L. Giovannucci, Alicja Wolk, Niclas Håkansson, Swen‐Olof Andersson, Jan‐Erik Johansson, Katja Fall, Lorelei A. Mucci	61

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact